Short Interest in Janone Inc. (NASDAQ:ALTS) Declines By 50.4%

Janone Inc. (NASDAQ:ALTS) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 62,900 shares, a decline of 50.4% from the December 31st total of 126,700 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average trading volume of 198,900 shares, the short-interest ratio is presently 0.3 days.

Janone Stock Performance

Janone stock opened at $5.53 on Thursday. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96. Janone has a 1-year low of $0.50 and a 1-year high of $7.09. The firm’s fifty day simple moving average is $4.23.

Janone Company Profile

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.